Effect of selenium-enriched malt on hypoglycemia and regulatory hormones in diethylnitrosamine-induced hepatocarcinoma SD rats

One hundred and ninety-three Sprague-Dawley (SD) rats (average body weight being 100–120 g) were randomly divided into 5 groups (I–V). Animals in group I and group II served as the negative control and positive control, respectively, and both received 0.1 mg/kg selenium (Se) from sodium selenite. Animals in groups III–V were fed with Se from Se-enriched malt (SEM) supplemented diets (0.3, 1 and 3 mg/kg, respectively). Simultaneously, hepatocarcinoma were induced in groups II–V by diethylnitrosamine (DEN) solution (100 mg/L) at the dosage of 10 mg/kg body weight every day as drinking water for 16 weeks, then sterilized water for a further two weeks. Rats of group I drank sterilized water during the whole experimental time. At 4th, 8th, 12th, 16th week, five rats in each group were then sacrificed by cervical decapitation. At the termination of the study, at 18th week, the surplus rats were sacrificed by cervical decapitation. Feed was withheld from the rats for 12 h before sampling. The values of plasma glucose at different sampling times were measured. The values of the hormones in plasma related to plasma glucose metabolism, including insulin, glucagon, insulin-like growth factors-II (IGF-II), and the ratios of insulin/glucose (IGR₁), insulin/glucagon (IGR₂) and glucagon/glucose (GGR) were determined. At the same time, the correlation of plasma glucose concentrations related to hormones was statistically analyzed. The results indicated that the values of plasma glucose, insulin, glucagon and GGR in the groups treated with DEN were decreased significantly as compared with that of the negative control group, however, the values of IGF-II and IGR₂ were increased significantly. SEM showed a significant effect in suppressing the decreased of plasma glucose and glucagons, and delaying the increased of IGF-II and IGR₂ in the DEN-induced hepatocarcinoma rats. The plasma glucose concentrations revealed a significant relation to the hormones. In conclusion, SEM could reduce the development of hypoglycemia in the DEN-induced hepatocarcinoma rats by regulating the relative levels and balances or proportions of hormones.     

Effect of Sonic Hedgehog signaling blockade on growth of hepatocarcinoma cells

AIM: To investigate the effect of Sonic Hedgehog (Shh) signaling blockade on the growth of hematocarcinoma cells and underlying mechanisms. METHODS: The expression of Shh signaling molecules in hematocarcinoma cell lines BEL-7402, Huh7 and HepG2 was detected by RT-PCR. The cell viability was detected by MTT assay. The cell cycle and apoptosis were analyzed by flow cytometry. The expression of apoptosis-related proteins was determined by Western blot. RESULTS: Shh signaling molecules were all expressed in BEL-7402, Huh7 and HepG2 cells. The mRNA expression of Patched (Ptch), Gli1 and Gli2 was down-regulated by anti-Shh antibody. Blockade of Shh signaling pathway inhibited the proliferation of hepatocarcinoma cells with increasing cells in G₀/G₁ phase and induced the apoptosis of hepatocarcinoma cells. Treatment with anti-Shh antibody down-regulated the protein expression of pro-caspase-3, pro-caspase-8 and pro-caspase-9, while up-regulated the protein levels of cleaved caspase-3, cleaved caspase-8 and cleaved caspase-9 in BEL-7402 cells. CONCLUSION: Blockade of Shh signaling pathway inhibits the growth of hepatocarcinoma at different levels by cell cycle arrest and inducing apoptosis of hematocarcinoma cells.     

槲皮素对CBRH-7919细胞增殖及线粒体膜电位的影响

[目的]探讨槲皮素对肝癌细胞株CBRH-7919增殖及线粒体膜电位的影响。[方法]体外培养肝癌CBRH-7919细胞,以不同浓度槲皮素处理细胞后,采用酸性磷酸酶(APA)法检测OD405;倒置显微镜观测CBRH-7919细胞形态变化;Rhodamine 123染色后流式细胞仪检测线粒体膜电位(△ψm)变化。[结果]槲皮素对肝癌CBRH-7919细胞有明显的增殖抑制作用,并与剂量和作用时间成正比;光学显微镜下可见槲皮素作用后细胞密度明显降低;经10μg/ml槲皮素作用122、4、48 h后,流式细胞术检测到Rhodamine 123染色弱荧光细胞百分比逐步增加,线粒体膜电位下降。[结论]槲皮素体外能抑制肝癌细胞株CBRH-7919增殖,引起线粒体膜电位下降。     

槲皮素对CBRH-7919细胞增殖及线粒体膜电位的影响(英文)

[目的]探讨槲皮素对肝癌细胞株CBRH-7919增殖及线粒体膜电位的影响。[方法]体外培养肝癌CBRH-7919细胞,以不同浓度槲皮素处理细胞后,采用酸性磷酸酶(APA)法检测OD405nm;倒置显微镜观测CBRH-7919细胞形态变化;Rhodamine123染色后流式细胞仪检测线粒体膜电位(△ψm)变化。[结果]槲皮素对肝癌CBRH-7919细胞有明显的增殖抑制作用,并与剂量和时间成正比。光学显微镜下可见槲皮素作用后细胞密度明显降低。经10μg/ml槲皮素作用12、24、48h后,流式细胞术检测到Rhodamine123染色弱荧光细胞百分比逐步增加,线粒体膜电位下降。[结论]槲皮素体外能抑制肝癌细胞株CBRH-7919增殖,引起线粒体膜电位下降。     

槲皮素对BEL-7402细胞生长抑制作用的研究

[目的]探讨槲皮素对人肝癌细胞株BEL-7402的增殖抑制及凋亡诱导作用。[方法]体外培养BEL-7402细胞,以不同浓度槲皮素处理细胞后,采用酸性磷酸酶（APA）法检测细胞增殖抑制率;光镜观测BEL-7402细胞形态变化;流式细胞仪检测细胞凋亡率。[结果]槲皮素对人肝癌BEL-7402细胞有明显的增殖抑制作用,其72h的IC50为4μg/ml。光学显微镜下可见细胞密度明显降低。经槲皮素作用6、12h后,流式细胞术检测到细胞凋亡率显著增加。[结论]槲皮素对人肝癌细胞的增殖抑制呈浓度相关性,可诱导肝癌细胞凋亡。